このページは機械翻訳されています。他のページは英語で表示される場合があります。 View in English

機械学習による潰瘍性大腸炎における炎症関連診断バイオマーカーと分子サブタイプの特定

  • 0Department of Gastroenterology, Lishui People's Hospital, No. 188 Liyang Street, Liandu District, Lishui, 323000, Zhejiang, China.

まとめ

この要約は機械生成です。

関連する概念動画

Inflammatory Bowel Disease I: Ulcerative Colitis 01:27

321

Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy 01:30

419

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...

Drugs for Treatment of Ulcerative Colitis in IBD 01:29

236

Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...